학술논문
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02–15 study)
Document Type
Article
Author
Source
In: Lung Cancer . (Lung Cancer, November 2021, 161:122-127)
Subject
Language
English
ISSN
18728332
01695002
01695002